Company / Current Assets
Sana Biotechnology, Inc. Current Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$160.8M
FY2024
5-year range
$160.8M / $558.1M
FY2020-FY2024
Trend
-24.7%
vs FY2023
Sector context
#196 of 213
Health Care
What the data says
Among 213 Health Care companies, Sana Biotechnology, Inc. is in the bottom 8% for current assets. Current Assets has declined for 3 consecutive years, from $558M in FY2021 to $161M in FY2024.
Based on SEC 10-K filings.
$161M in FY2024 with a 3-year CAGR of -34.0%.
Declined from $444M to $161M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -34.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 213This company $160.8M Sector average $2.5B
▼
-93.6% below sector average
Key checks
Key Insights
- Sana Biotechnology, Inc.'s current assets has declined for 3 consecutive years.
- 3-year CAGR of -34.0%, indicating a declining trend.
- In FY2024, current assets decreased 24.7% year-over-year.
- Ranks #196 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $160.8M | -24.7% |
| FY2023 | $213.5M | -52.0% |
| FY2022 | $444.4M | -20.4% |
| FY2021 | $558.1M | +45.2% |
| FY2020 | $384.5M | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026